Infrared Non-Cutting Laser Therapy for Acne

Inclusion Criteria: Age 13 years or older of either gender and of any racial/ethnic group. Subjects must have clinically evident acne vulgaris of the facial skin. Subjects must understand and sign the informed consent prior to participation. Subjects must be in generally good health. Subjects must be able and willing to comply with the requirements of the protocol. You must live within a reasonable driving distance of Ann Arbor, Michigan, and/or be able to attend all of the scheduled appointments during the study. Exclusion Criteria: Oral retinoid (Accutane) use within 1 year of entry into the study. Systemic acne therapies (oral antibiotics) within 4 weeks of entry into the study. Topical acne therapies (retinoids, antibiotics) within 2 weeks of entry into the study. Microdermabrasion or superficial chemical peels at the sites to be treated within 3 months of entry into the study. Subjects with a history of dermabrasion or laser resurfacing at the sites to be treated. Use of topical lipid absorbing substances (Clinac AC) within 2 weeks of entry into the study. Non-compliant subjects. Subjects with a significant medical history or concurrent illness/condition which the investigator(s) feel is not safe for study participation. Subjects using alcohol-based topical solutions or "exfolliating" agents within 2 weeks of entry into the study. Subjects with a history of very frequent herpes simplex infections of the face or with clinical evidence of active herpes simplex infections. History of keloid scar formation for subjects undergoing biopsies. Pregnant or nursing females.